Observational studyBasic & clinical pharmacology & toxicology2026
Frequency of Clinically Relevant Drug-Drug Interactions Between Tyrosine Kinase Inhibitors and Proton Pump Inhibitors in Patients With Cancer Using Real-World Data.
Grietje van Elp et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.